Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Knutson

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compoundJ W Coburn, A U Tan, B S Levine, et al.
Biochemical Pharmacology|July 12, 1996
Anti-proliferative activity and target cell catabolism of the vitamin D analog 1 alpha,24(S)-(OH)2D2 in normal and immortalized human epidermal cellsG Jones, V Byford, H L Makin, et al.
American Journal of Medical Genetics|November 1, 1993
Tetrasomy 9p: tissue-limited idic(9p) in a child with mild manifestations and a normal CVS result. Report and reviewF S Grass, J C Parke, H N Kirkman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2021
Evaluation of Motion Compensation Methods for Noninvasive Cardiac Radioablation of Ventricular TachycardiaMichael T Prusator, Pamela Samson, Jochen Cammin, et al.
Advances in Radiation Oncology|August 11, 2020
Implementing a Novel Remote Physician Treatment Coverage Practice for Adaptive Radiation Therapy During the Coronavirus PandemicAlex Price, Hyun Kim, Lauren E Henke, et al.
American Journal of Nephrology|November 24, 2016
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized TrialRavi Thadhani, Julia B Zella, Danielle C Knutson, et al.
The Biochemical Journal|August 15, 1995
1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3BS Strugnell, V Byford, H L Makin, et al.
Journal of Applied Clinical Medical Physics|December 10, 2020
Filmless quality assurance of a Leksell Gamma Knife® Icon™Borna Maraghechi, Taeho Kim, Timothy J Mitchell, et al.
Kidney International|January 1, 1997
Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidismA U Tan, B S Levine, R B Mazess, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2026
STAR Power: Noninvasive Radiotherapy for Ventricular Tachycardia Enters a New EraCarmen Bergom, Nels C Knutson, Shannon Jiang, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compoundJ W Coburn, A U Tan, B S Levine, et al.
Biochemical Pharmacology|July 12, 1996
Anti-proliferative activity and target cell catabolism of the vitamin D analog 1 alpha,24(S)-(OH)2D2 in normal and immortalized human epidermal cellsG Jones, V Byford, H L Makin, et al.
American Journal of Medical Genetics|November 1, 1993
Tetrasomy 9p: tissue-limited idic(9p) in a child with mild manifestations and a normal CVS result. Report and reviewF S Grass, J C Parke, H N Kirkman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2021
Evaluation of Motion Compensation Methods for Noninvasive Cardiac Radioablation of Ventricular TachycardiaMichael T Prusator, Pamela Samson, Jochen Cammin, et al.
Advances in Radiation Oncology|August 11, 2020
Implementing a Novel Remote Physician Treatment Coverage Practice for Adaptive Radiation Therapy During the Coronavirus PandemicAlex Price, Hyun Kim, Lauren E Henke, et al.
American Journal of Nephrology|November 24, 2016
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized TrialRavi Thadhani, Julia B Zella, Danielle C Knutson, et al.
The Biochemical Journal|August 15, 1995
1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3BS Strugnell, V Byford, H L Makin, et al.
Journal of Applied Clinical Medical Physics|December 10, 2020
Filmless quality assurance of a Leksell Gamma Knife® Icon™Borna Maraghechi, Taeho Kim, Timothy J Mitchell, et al.
Kidney International|January 1, 1997
Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidismA U Tan, B S Levine, R B Mazess, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2026
STAR Power: Noninvasive Radiotherapy for Ventricular Tachycardia Enters a New EraCarmen Bergom, Nels C Knutson, Shannon Jiang, et al.
Pageof 10